We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+20.89%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.13B
AUM Growth
+$563M
Cap. Flow
-$172M
Cap. Flow %
-2.8%
Top 10 Hldgs %
24.72%
Holding
175
New
20
Increased
65
Reduced
40
Closed
23

Top Buys

Rank Stock Value
1
CLDX icon
Celldex Therapeutics
CLDX
+$59.7M
2
ZNTL icon
Zentalis Pharmaceuticals
ZNTL
+$54.7M
3
LXEO icon
Lexeo Therapeutics
LXEO
+$37.3M
4
MNDY icon
monday.com
MNDY
+$32.9M
5
XMTR icon
Xometry
XMTR
+$28.5M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$79.8M
2
EXAS
Exact Sciences
EXAS
+$51.4M
3
SHLS icon
Shoals Technologies Group
SHLS
+$42.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$39.3M
5
MIRM icon
Mirum Pharmaceuticals
MIRM
+$39.2M

Sector Composition

Rank Sector Weight
1 Healthcare 39.38%
2 Technology 24.68%
3 Industrials 16.87%
4 Consumer Discretionary 8.76%
5 Communication Services 2.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XMTR icon
1
Xometry
XMTR
$4.69B
$204M 3.34%
5,690,345
+1,331,032
+31% +$28.5M
TT icon
2
Trane Technologies
TT
$97.3B
$195M 3.18%
799,761
+9,141
+1% +$2M
ZNTL icon
3
Zentalis Pharmaceuticals
ZNTL
$350M
$175M 2.86%
11,559,975
+3,745,936
+48% +$54.7M
ODFL icon
4
Old Dominion Freight Line
ODFL
$44.2B
$171M 2.79%
842,826
-44,978
-5% -$8.92M
CLDX icon
5
Celldex Therapeutics
CLDX
$3.02B
$144M 2.35%
3,630,013
+2,030,013
+127% +$59.7M
ROP icon
6
Roper Technologies
ROP
$38.5B
$129M 2.1%
236,513
-594
-0.3% -$306K
CRWD icon
7
CrowdStrike
CRWD
$189B
$128M 2.08%
1,997,700
+124
+0% +$6.49K
IDXX icon
8
Idexx Laboratories
IDXX
$44.1B
$124M 2.03%
223,973
-91
-0% -$42.7K
PANW icon
9
Palo Alto Networks
PANW
$265B
$123M 2.01%
837,006
-228,850
-21% -$30.6M
WCN
10
Waste Connections
WCN
$41.9B
$121M 1.97%
810,022
+5,540
+0.7% +$761K
DHI icon
11
D.R. Horton
DHI
$40.7B
$119M 1.94%
780,746
+29,552
+4% +$3.64M
POOL icon
12
Pool Corp
POOL
$6.95B
$114M 1.86%
286,096
-1,003
-0.3% -$352K
GH icon
13
Guardant Health
GH
$20.2B
$105M 1.72%
3,888,146
+298,616
+8% +$7.83M
GLBE icon
14
Global E Online
GLBE
$6.7B
$97.7M 1.59%
2,464,197
+13,350
+0.5% +$481K
FLYW icon
15
Flywire
FLYW
$2.01B
$97.3M 1.59%
4,203,264
+131,996
+3% +$3.33M
DDOG icon
16
Datadog
DDOG
$95.6B
$96.8M 1.58%
797,521
+66,588
+9% +$6.86M
SWAV
17
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$96.5M 1.57%
506,220
+150,503
+42% +$28.4M
DLO icon
18
dLocal
DLO
$4.41B
$95.9M 1.57%
5,422,563
-49,321
-0.9% -$882K
ARGX icon
19
argenx
ARGX
$54.6B
$93.5M 1.53%
245,771
-75,584
-24% -$35.2M
LAD icon
20
Lithia Motors
LAD
$9.24B
$88.2M 1.44%
267,877
+20,363
+8% +$5.59M
MTD icon
21
Mettler-Toledo International
MTD
$27.9B
$87.7M 1.43%
72,323
-36,065
-33% -$39M
EVH icon
22
Evolent Health
EVH
$358M
$87.2M 1.42%
2,638,946
+6
+0% +$170
HUBS icon
23
HubSpot
HUBS
$11.9B
$82M 1.34%
141,239
+1,146
+0.8% +$551K
COLL icon
24
Collegium Pharmaceutical
COLL
$1.17B
$81M 1.32%
2,630,478
-856
-0% -$21.4K
LOW icon
25
Lowe's Companies
LOW
$118B
$80.8M 1.32%
363,076
-83,374
-19% -$16.9M
1
2 3 4 5

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2023 Portfolio in Review

As of Q4 2023, Eventide Asset Management held 175 positions worth $6.13B, up 10% from $5.56B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q4 2023 filing shows 20 new, 65 increased, 40 reduced and 23 closed positions. Its largest new stake was Lexeo Therapeutics: 3,002,831 shares worth $40.3M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $79.8M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2023 buy was Lexeo Therapeutics: 3,002,831 shares worth $40.3M.
  • Eventide Asset Management added most to Celldex Therapeutics in Q4 2023, an estimated $59.7M increase.
  • Eventide Asset Management's biggest Q4 2023 reduction was Exact Sciences, cutting an estimated $51.4M.
  • Eventide Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $79.8M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $6.13B portfolio in Q4 2023.
  • Eventide Asset Management opened 20 new positions and closed 23 in Q4 2023.
  • Eventide Asset Management's portfolio value rose 10% quarter-over-quarter to $6.13B.

Based on Eventide Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.